List of Figures
List of Figures
- Figure 1: Share of Leading TNF inhibitor drugs in market for Ulcerative colitis in U.S, 2020
- Figure 2: Prevalence of Irritable Bowel Disease, 2019 in WHO regions
- Figure 3: Incidence of Irritable Bowel Disease, 2019 in WHO regions
- Figure 4: Global Irritable bowel disease Market Size, By Value, 2019-2022 (USD Billion)
- Figure 5: Global Irritable bowel disease Market Size, By Value, 2023-2029 (USD Billion)
- Figure 6: Global Irritable bowel disease Market Share, By Drug Class, 2022 (%)
- Figure 7: Market Attractiveness Analysis of Global Irritable Bowel Disease Market, By Drug Class (2024-2029)
- Figure 8: Global Irritable bowel disease Market Size, By Corticosteroids, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 9: Global Irritable bowel disease Market Absolute Opportunity, By Corticosteroids, 2019-2029 (USD Billion)
- Figure 10: Global Irritable bowel disease Market Size, By JAK inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 11: Global Irritable bowel disease Market Absolute Opportunity, By JAK inhibitors, 2019-2029 (USD Billion)
- Figure 12: Global Irritable bowel disease Market Size, By TNF inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 13: Global Irritable bowel disease Market Absolute Opportunity, By TNF inhibitors, 2019-2029 (USD Billion)
- Figure 14: Global Irritable bowel disease Market Size, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 15: Global Irritable bowel disease Market Absolute Opportunity, By Other Drug Classes, 2019-2029 (USD Billion)
- Figure 16: Market Attractiveness Analysis of Global Irritable Bowel Disease Market, By Route of Administration (2024-2029)
- Figure 17: Global Irritable Bowel Disease Market Size, By Injectable, By Value, 2019H-2029F (USD Billions & CAGR)
- Figure 18: Global Irritable Bowel Disease Market Absolute Opportunity, By Injectable, 2019-2029 (USD Billion)
- Figure 19: Global Irritable Bowel Disease Market Size, By Oral, By Value, 2019H-2029F (USD Billions & CAGR)
- Figure 20: Global Irritable Bowel Disease Market Absolute Opportunity, By Oral, 2019-2029 (USD Billion)
- Figure 21: Market Attractiveness Analysis of Global Irritable Bowel Disease Market, By Indication (2024-2029)
- Figure 22: Global Irritable Bowel Disease Market Size, By Crohn's Disease, By Value, 2019H-2029F (USD Billions & CAGR)
- Figure 23: Global Irritable bowel disease Market Absolute Opportunity, By Crohn's Disease, 2019-2029 (USD Billion)
- Figure 24: Global Irritable bowel disease Market Size, By Ulcerative Colitis, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 25: Global Irritable bowel disease Market Absolute Opportunity, By Ulcerative Colitis, 2019-2029 (USD Billion)
- Figure 26: Americas Irritable bowel disease Market Size, By Value, 2019H-2029F (USD Billion)
- Figure 27: Americas Irritable bowel disease Market Share, By Drug Class, 2022 (%)
- Figure 28: Americas Irritable bowel disease Market, By Corticosteroids, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 29: Americas Irritable bowel disease Market, By JAK inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 30: Americas Irritable bowel disease Market, By TNF inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 31: Americas Irritable bowel disease Market, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 32: Americas Irritable bowel disease Market, By Injectable, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 33:Americas Irritable bowel disease Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 34: Americas Irritable bowel disease Market, By Crohn's Disease, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 35: Americas Irritable bowel disease Market, By Ulcerative Colitis, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 36: United States Irritable bowel disease Market, By Value, 2019-2029 (USD Billion & CAGR)
- Figure 37: United States Irritable bowel disease Market Value, By Indication, 2022 (USD Billion)
- Figure 38: United States Irritable bowel disease Market Share, By Drug Class, By Value, 2022 (%)
- Figure 39: United States Irritable bowel disease Market Share, By Route of Administration, By Value, 2022 (%)
- Figure 40: United States Irritable bowel disease Market Share, By Indication, 2022 (%)
- Figure 41: Canada Irritable bowel disease Market, By Value, 2019-2029 (USD Billion & CAGR)
- Figure 42: Canada Irritable bowel disease Market Value, By Indication, 2022 (USD Billion)
- Figure 43: Canada Irritable bowel disease Market Share, By Drug Class, By Value, 2022 (%)
- Figure 44: Canada Irritable bowel disease Market Share, By Route of Administration, By Value, 2022 (%)
- Figure 45: Canada Irritable bowel disease Market Share, By Indication, 2022 (%)
- Figure 46: Rest of Americas Irritable bowel disease Market, By Value, 2019-2029 (USD Billion & CAGR)
- Figure 47: Rest of Americas Irritable bowel disease Market Value, By Indication, 2022 (USD Billion)
- Figure 48: Rest of Americas Irritable bowel disease Market Share, By Drug Class, By Value, 2022 (%)
- Figure 49: Rest of Americas Irritable bowel disease Market Share, By Route of Administration, 2022 (%)
- Figure 50: Rest of Americas Irritable bowel disease Market Share, By Indication, 2022 (%)
- Figure 51: Europe Irritable bowel disease Market Size, By Value, 2019H-2029F (USD Billion)
- Figure 52: Europe Irritable bowel disease Market Share, By Indication, 2022 (%)
- Figure 53:Europe Irritable bowel disease Market, By Corticosteroids, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 54: Europe Irritable bowel disease Market, By JAK inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 55: Europe Irritable bowel disease Market, By TNF inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 56: Europe Irritable bowel disease Market, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 57: Europe Irritable bowel disease Market, By Injectable, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 58: Europe Irritable bowel disease Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 59: Europe Irritable bowel disease Market, By Crohn's Disease, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 60: Europe Irritable bowel disease Market, By Ulcerative Colitis, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 61: United Kingdom Irritable bowel disease Market, By Value, 2019-2029 (USD Billion & CAGR)
- Figure 62: United Kingdom Irritable bowel disease Market Value, By Indication, 2022 (USD Billion)
- Figure 63: United Kingdom Irritable bowel disease Market Share, By Drug Class, By Value, 2022 (%)
- Figure 64: United Kingdom Irritable bowel disease Market Share, By Route of Administration, By Value, 2022 (%)
- Figure 65: United Kingdom Irritable bowel disease Market Share, By Indication, 2022 (%)
- Figure 66: Germany Irritable Bowel Disease Market, By Value, 2019-2029 (USD Billions & CAGR)
- Figure 67: Germany Irritable Bowel Disease Market Value, By Indication, 2022 (USD Billion)
- Figure 68: Germany Irritable Bowel Disease Market Share, By Drug Class, By Value, 2022 (%)
- Figure 69: Germany Irritable Bowel Disease Market Share, By Route of Administration, By Value, 2022 (%)
- Figure 70: Germany Irritable Bowel Disease Market Share, By Indication, By Value, 2022 (%)
- Figure 71: France Irritable Bowel Disease Market, By Value, 2019-2029 (USD Billions & CAGR)
- Figure 72: France Irritable Bowel Disease Market Value, By Indication, 2022 (USD Billion)
- Figure 73: France Irritable Bowel Disease Market Share, By Drug Class, By Value, 2022 (%)
- Figure 74: France Irritable Bowel Disease Market Share, By Route of Administration, By Value, 2022 (%)
- Figure 75: France Irritable Bowel Disease Market Share, By Indication, By Value, 2022 (%)
- Figure 76: Italy Irritable Bowel Disease Market, By Value, 2019-2029 (USD Billions & CAGR)
- Figure 77: Italy Irritable Bowel Disease Market Value, By Indication, 2022 (USD Billion)
- Figure 78: Italy Irritable Bowel Disease Market Share, By Drug Class, By Value, 2022 (%)
- Figure 79: Italy Irritable bowel disease Market Share, By Route of Administration, 2022 (%)
- Figure 80: Italy Irritable bowel disease Market Share, By Indication, 2022 (%)
- Figure 81: Spain Irritable bowel disease Market, By Value, 2019-2029 (USD Billion & CAGR)
- Figure 82: Spain Irritable bowel disease Market Value, By Indication, 2022 (USD Billion)
- Figure 83: Spain Irritable bowel disease Market Share, By Drug Class, By Value, 2022 (%)
- Figure 84: Spain Irritable bowel disease Market Share, By Route of Administration, 2022 (%)
- Figure 85: Spain Irritable bowel disease Market Share, By Indication, 2022 (%)
- Figure 86: Rest of Europe Irritable bowel disease Market, By Value, 2019-2029 (USD Billion & CAGR)
- Figure 87: Rest of Europe Irritable bowel disease Market Value, By Indication, 2022 (USD Billion)
- Figure 88: Rest of Europe Irritable bowel disease Market Share, By Drug Class, By Value, 2022 (%)
- Figure 89: Rest of Europe Irritable bowel disease Market Share, By Route of Administration, 2022 (%)
- Figure 90: Rest of Europe Irritable bowel disease Market Share, By Indication, 2022 (%)
- Figure 91: Asia Pacific Irritable Bowel Disease Market Size, By Value, 2019H-2029F (USD Billion)
- Figure 92: Asia Pacific Irritable Bowel Disease Market Share, By Indication, 2022 (%)
- Figure 93: Asia Pacific Irritable bowel disease Market, By Corticosteroids, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 94: Asia Pacific Irritable bowel disease Market, By JAK inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 95: Asia Pacific Irritable bowel disease Market, By TNF inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 96: Asia Pacific Irritable Bowel Disease Market, By Other Drug Classes, By Value, 2019H-2029F (USD Billions & CAGR)
- Figure 97: Asia Pacific Irritable bowel disease Market, By Injectable, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 98: Asia Pacific Irritable bowel disease Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 99: Asia Pacific Irritable bowel disease Market, By Crohn's Disease, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 100: Asia Pacific Irritable bowel disease Market, By Ulcerative Colitis, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 101: China Irritable bowel disease Market, By Value, 2019-2029 (USD Billion & CAGR)
- Figure 102: China Irritable bowel disease Market Value, By Indication, 2022 (USD Billion)
- Figure 103: China Irritable bowel disease Market Share, By Drug Class, By Value, 2022 (%)
- Figure 104: China Irritable bowel disease Market Share, By Route of Administration, 2022 (%)
- Figure 105: China Irritable bowel disease Market Share, By Indication, 2022 (%)
- Figure 106: Japan Irritable bowel disease Market, By Value, 2019-2029 (USD Billion & CAGR)
- Figure 107: Japan Irritable bowel disease Market Value, By Indication, 2022 (USD Billion)
- Figure 108: Japan Irritable bowel disease Market Share, By Drug Class, By Value, 2022 (%)
- Figure 109: Japan Irritable bowel disease Market Share, By Route of Administration, 2022 (%)
- Figure 110: Japan Irritable bowel disease Market Share, By Indication, 2022 (%)
- Figure 111: India Irritable bowel disease Market, By Value, 2019-2029 (USD Billion & CAGR)
- Figure 112: India Irritable bowel disease Market Value, By Indication, 2022 (USD Billion)
- Figure 113: India Irritable bowel disease Market Share, By Drug Class, By Value, 2022 (%)
- Figure 114: India Irritable bowel disease Market Share, By Route of Administration, 2022 (%)
- Figure 115: India Irritable bowel disease Market Share, By Indication, 2022 (%)
- Figure 116: Rest of Asia Pacific Irritable bowel disease Market, By Value, 2019-2029 (USD Billion & CAGR)
- Figure 117: Rest of Asia Pacific Irritable bowel disease Market Value, By Indication, 2022 (USD Billion)
- Figure 118: Rest of Asia Pacific Irritable bowel disease Market Share, By Drug Class, By Value, 2022 (%)
- Figure 119: Rest of Asia Pacific Irritable bowel disease Market Share, By Route of Administration, 2022 (%)
- Figure 120: Rest of Asia Pacific Irritable bowel disease Market Share, By Indication, 2022 (%)
- Figure 121: Middle East and Africa Irritable Bowel Disease Market Size, By Value, 2019H-2029F (USD Billion)
- Figure 122: Middle East and Africa Irritable bowel disease Market Share, By Indication, 2022 (%)
- Figure 123: Middle East and Africa Irritable bowel disease Market, By Corticosteroids, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 124: Middle East and Africa Irritable bowel disease Market, By JAK inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 125: Middle East and Africa Irritable bowel disease Market, By TNF inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 126: Middle East and Africa Irritable bowel disease Market, By Other Indications, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 127: Middle East and Africa Irritable bowel disease Market, By Injectable, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 128: Middle East and Africa Irritable bowel disease Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 129: Middle East and Africa Irritable bowel disease Market, By Crohn's Disease, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 130: Middle East and Africa Irritable bowel disease Market, By Ulcerative Colitis, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 131: Market Share of Prominent Companies of Irritable bowel disease Market, 2022 (%)
- Figure 132: Johnson & Johnson Revenues, 2020-2022 (USD Million)
- Figure 133: Johnson & Johnson Revenues, By Geographic Segments, 2022 (%)
- Figure 134: Johnson & Johnson Revenue , By Business Segments, 2022 (%)
- Figure 135: Pfizer Revenues, 2020-2022 (USD Million)
- Figure 136: Pfizer Revenues, By Business Segments, 2022 (%)
- Figure 137: Pfizer Inc. Revenue , By Geographical Segments, 2022 (%)
- Figure 138: Novartis Revenue, 2020-2022 (USD Million)
- Figure 139: Novartis Revenue, By Business Segments, 2022 (%)
- Figure 140: Novartis Revenue, By Geographical Segments, 2022 (%)
- Figure 141: Eli Lilly and Company Revenues, 2020-2022 (USD Million)
- Figure 142: Eli Lilly and Company Revenues, By Geographic Segments, 2022 (%)
- Figure 143: Eli Lilly and Company Revenue , By Therapeutic Area, 2022 (%)
- Figure 144: AbbVie Inc.Revenues, 2020-2022 (USD Million)
- Figure 145: AbbVie Inc.Revenue , Product Category, 2022 (%)
- Figure 146: AbbVie Inc.Revenue , By Geographical Segments, 2022 (%)
- Figure 147: GSK PLC Revenue, 2020-2022 (USD Million)
- Figure 148: GSK PLC Revenue , By Business Segments, 2022 (%)
- Figure 149: GSK PLC Revenue, By Geography Segment, 2022 (%)
- Figure 150: UCB S.A. Revenue, 2020-2022 (USD Million)
- Figure 151: UCB S.A. Revenue , By Business Segments, 2022 (%)
- Figure 152: UCB S.A. Revenue, By Geography Segment, 2022 (%)
- Figure 153: Takeda Pharmaceuticals Revenues, 2019-2021 (USD Million)
- Figure 154: Takeda Pharmaceuticals Revenues, By Geographic Segments, 2021 (%)
- Figure 155: Takeda Pharmaceuticals Revenue , By Business Segments, 2021 (%)
- Figure 156: Bristol-Myers Squibb Revenues, 2020-2022 (USD Million)
- Figure 157: Bristol-Myers Squibb Revenues, By Geographic Segments, 2022 (%)
- Figure 158: Celltrion Revenues, 2020-2022 (USD Billion)
- Figure 159: Celltrion Revenues, By Geographic Segments, 2022 (%)
- Figure 160: Celltrion Revenue , By Therapeutic Area, 2022 (%)
List of Tables
Table A1: Global Impact of Macro Economic Factors, By Region
Table A2: Select emergent therapies in clinical development for UC
Table A3: United States Irritable bowel disease Market, By Drug Class, By Value, 2019-2022 (USD Billion)
Table A4: United States Irritable bowel disease Market, By Drug Class, By Value, 2023-2029 (USD Billion)
Table A5: United States Irritable bowel disease Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A6: United States Irritable bowel disease Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A7: United States Irritable bowel disease Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A8: United States Irritable bowel disease Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A9: Canada Irritable bowel disease Market, By Drug Class, By Value, 2019-2022 (USD Billion)
Table A10: Canada Irritable bowel disease Market, By Drug Class, By Value, 2023-2029 (USD Billion)
Table A11: Canada Irritable bowel disease Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A12: Canada Irritable bowel disease Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A13: Canada Irritable bowel disease Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A14: Canada Irritable bowel disease Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A15: Rest of Americas Irritable bowel disease Market, By Drug Class, By Value, 2019-2022 (USD Billion)
Table A16: Rest of AmericasIrritable bowel disease Market, By Drug Class, By Value, 2023-2029 (USD Billion)
Table A17: Rest of AmericasIrritable bowel disease Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A18: Rest of AmericasIrritable bowel disease Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A19: Rest of AmericasIrritable bowel disease Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A20: Rest of AmericasIrritable bowel disease Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A21: United Kingdom Irritable bowel disease Market, By Drug Class, By Value, 2019-2022 (USD Billion)
Table A22: United Kingdom Irritable bowel disease Market, By Drug Class, By Value, 2023-2029 (USD Billion)
Table A23: United Kingdom Irritable bowel disease Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A24: United Kingdom Irritable bowel disease Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A25: United Kingdom Irritable bowel disease Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A26: United Kingdom Irritable bowel disease Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A27: Germany Irritable bowel disease Market, By Drug Class, By Value, 2019-2022 (USD Billion)
Table A28: Germany Irritable bowel disease Market, By Drug Class, By Value, 2023-2029 (USD Billion)
Table A29: Germany Irritable bowel disease Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A30: Germany Irritable bowel disease Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A31: Germany Irritable bowel disease Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A32: Germany Irritable bowel disease Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A33:France Irritable bowel disease Market, By Drug Class, By Value, 2019-2022 (USD Billion)
Table A34: France Irritable bowel disease Market, By Drug Class, By Value, 2023-2029 (USD Billion)
Table A35: France Irritable bowel disease Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A36: France Irritable bowel disease Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A37: France Irritable bowel disease Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A38: France Irritable bowel disease Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A39: Italy Irritable bowel disease Market, By Drug Class, By Value, 2019-2022 (USD Billion)
Table A40: Italy Irritable bowel disease Market, By Drug Class, By Value, 2023-2029 (USD Billion)
Table A41: Italy Irritable bowel disease Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A42: Italy Irritable bowel disease Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A43: Italy Irritable bowel disease Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A44: Italy Irritable bowel disease Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A45: Spain Irritable bowel disease Market, By Drug Class, By Value, 2019-2022 (USD Billion)
Table A46: Spain Irritable bowel disease Market, By Drug Class, By Value, 2023-2029 (USD Billion)
Table A47: Spain Irritable bowel disease Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A48: Spain Irritable bowel disease Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A49: Spain Irritable bowel disease Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A50: Spain Irritable bowel disease Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A51: Rest of Europe Irritable bowel disease Market, By Drug Class, By Value, 2019-2022 (USD Billion)
Table A52: Rest of Europe Irritable bowel disease Market, By Drug Class, By Value, 2023-2029 (USD Billion)
Table A53:Rest of Europe Irritable bowel disease Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A54: Rest of Europe Irritable bowel disease Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A55: Rest of Europe Irritable bowel disease Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A56: Rest of Europe Irritable bowel disease Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A57: China Irritable bowel disease Market, By Drug Class, By Value, 2019-2022 (USD Billion)
Table A58: China Irritable bowel disease Market, By Drug Class, By Value, 2023-2029 (USD Billion)
Table A59: China Irritable bowel disease Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A60: China Irritable bowel disease Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A61: China Irritable bowel disease Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A62: China Irritable bowel disease Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A63: Japan Irritable bowel disease Market, By Drug Class, By Value, 2019-2022 (USD Billion)
Table A64: Japan Irritable bowel disease Market, By Drug Class, By Value, 2023-2029 (USD Billion)
Table A65: Japan Irritable bowel disease Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A66: Japan Irritable bowel disease Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A67: Japan Irritable bowel disease Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A68: Japan Irritable bowel disease Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A69: India Irritable bowel disease Market, By Drug Class, By Value, 2019-2022 (USD Billion)
Table A70: India Irritable bowel disease Market, By Drug Class, By Value, 2023-2029 (USD Billion)
Table A71: India Irritable bowel disease Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A72: India Irritable bowel disease Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A73: India Irritable bowel disease Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A74: India Irritable bowel disease Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A75: Rest of Asia Pacific Irritable bowel disease Market, By Drug Class, By Value, 2019-2022 (USD Billion)
Table A76: Rest of Asia Pacific Irritable bowel disease Market, By Drug Class, By Value, 2023-2029 (USD Billion)
Table A77: Rest of Asia Pacific Irritable bowel disease Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A78: Rest of Asia Pacific Irritable bowel disease Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A79: Rest of Asia Pacific Irritable bowel disease Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A80: Rest of Asia Pacific Irritable bowel disease Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A81: Johnson & Johnson Key Financials, 2020-2022
Table A82: Pfizer Key Financials, 2020-2022
Table A83: Novartis Key Company Financials, 2020-2022
Table A84: Eli Lilly and Company Key Financials, 2020-2022
Table A85: AbbVie Inc Key Company Financials, 2020-2021
Table A86: GSK PLC Key Company Financials, 2020-2022
Table A87: UCB S.A. Key Company Financials, 2020-2022
Table A88: Takeda Pharmaceuticals Key Company Financials, 2020-2022
Table A89: Bristol-Myers Squibb Key Company Financials, 2020-2022
Table A90: Celltrion Key Company Financials, 2020-2022